Drug name - Zepatier

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7973040 MERCK SHARP DOHME Macrocyclic quinoxaline compounds as HCV NS3 protease inhibitors
Jul, 2029

(6 years from now)

US8871759 MERCK SHARP DOHME Inhibitors of hepatitis C virus replication
May, 2031

(8 years from now)

CN102159285B MERCK SHARP DOHME Quinoxaline Compound As Hcv Ns3 Macrocyclic Protease Inhibitor
Jul, 2029

(6 years from now)

CN102159285A MERCK SHARP DOHME Macrocyclic Quinoxaline Compounds As Hcv Ns3 Protease Inhibitors
Jul, 2029

(6 years from now)

CN102427729B MERCK SHARP DOHME Inhibitor Of Hepatitis C Virus Replication
Mar, 2030

(7 years from now)

CN103880862A MERCK SHARP DOHME Inhibitor Of Hepatitis C Virus Replication
Mar, 2030

(7 years from now)

CN103880862B MERCK SHARP DOHME Inhibitors Of Hepatitis C Virus Replication
Mar, 2030

(7 years from now)

CN102427729A MERCK SHARP DOHME Inhibitor Of Hepatitis C Virus Replication
Mar, 2030

(7 years from now)

EP2540350A1 MERCK SHARP DOHME Combinations Of A Macrocyclic Quinoxaline Compound Which Is An Hcv Ns3 Protease Inhibitor With Other Hcv Agents
Jul, 2029

(6 years from now)

EP2540349A1 MERCK SHARP DOHME Pharmaceutical Compositions Comprising A Macrocyclic Quinoxaline Compound Which Is An Hcv Ns3 Protease Inhibitor
Jul, 2029

(6 years from now)

EP2540350B1 MERCK SHARP DOHME Combinations Of A Macrocyclic Quinoxaline Compound Which Is An Hcv Ns3 Protease Inhibitor With Other Hcv Agents
Jul, 2029

(6 years from now)

EP2540349B1 MERCK SHARP DOHME Pharmaceutical Compositions Comprising A Macrocyclic Quinoxaline Compound Which Is An Hcv Ns3 Protease Inhibitor
Jul, 2029

(6 years from now)

EP2310095B1 MERCK SHARP DOHME Macrocyclic Quinoxaline Compounds As Hcv Ns3 Protease Inhibitors
Jul, 2029

(6 years from now)

EP2310095A1 MERCK SHARP DOHME Macrocyclic Quinoxaline Compounds As Hcv Ns3 Protease Inhibitors
Jul, 2029

(6 years from now)

EP2410844B1 MERCK SHARP DOHME Inhibitors Of Hepatitis C Virus Replication
Mar, 2030

(7 years from now)

EP2410844A4 MERCK SHARP DOHME Inhibitors Of Hepatitis C Virus Replication
Mar, 2030

(7 years from now)

EP2410844A1 MERCK SHARP DOHME Inhibitors Of Hepatitis C Virus Replication
Mar, 2030

(7 years from now)

More Information on Dosage
Strength Dosage Availability
50MG;100MG TABLET;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.